PRESS

IN THE NEWS

Press Release

SCIENTIFIC PEER REVIEW OF THE PROSTATE CANCER RESEARCH
PROGRAM FOR THE DEPARTMENT OF DEFENSE

For Immediate Press Release:

The Peer Reviewed Prostate Cancer Research Program (PCRP) consumer advocate Tom Hulsey recently participated in the evaluation of research applications submitted to the PCRP sponsored by the Department of Defense. Tom Hulsey was nominated for participation in the program by ZERO The End of Prostate Cancer. As a consumer reviewer, he was a full voting member, (along with prominent scientists) at meetings to help determine how the $100 million appropriated by Congress for Fiscal Year 2018 will be spent on PCRP research.

Consumer reviewers are asked to represent the collective view of patients by preparing comments on the impact of the research on issues such as diagnosis, treatment, and quality of life. When commenting on serving as a consumer reviewer, Tom said, “the advocacy work we (ZERO) do and the PCRP peer review go hand in hand. It is vital to protect and grow federal funding in order to ensure researchers have resources to develop new treatments and early detection methods.”

Consumer advocates and scientists have worked together in this unique partnership to evaluate the scientific merit of research applications since FY97. Colonel Stephen J. Dalal, Director of the Congressionally Directed Medical Research Programs, expressed his appreciation for the consumer advocate’s perspective during the scientific review sessions. “Consumer advocates are an integral part of the CDMRP’s scientific review process. They provide a key ingredient to the review process, the patient’s perspective, which is real and urgent. The collaboration of Consumer advocates alongside the scientists’ subject matter expertise is a truly unique collaboration that is difficult to find in most medical research programs.”

Scientists applying propose to conduct innovative research focused on the elimination of death from prostate cancer and enhancing the well-being of patients experiencing the impact of prostate cancer. The PCRP fills important gaps not addressed by other funding agencies by supporting groundbreaking, high-risk, high-gain research while encouraging out-of-the-box thinking.

More information about the DOD’s PCRP is available at the
Website: http://cdmrp.army.mil/pcrp/default..

Tom Hulsey and Dr. Melissa Cunningham, Congressionally Directed Medical Research Programs Project Manager


Media Contact:
Erin Bolling, Public Affairs, 301-619-7783
erin.e.bolling.ctr@mail.mil

Recommend / Share :